Alona Zer
@zeralona
Head, Department of Medical Oncology @RambamHCC Technion University - thoracic oncology & sarcoma 🏳️🌈🇮🇱
ID: 1089966370870214659
28-01-2019 19:20:08
412 Tweet
599 Takipçi
311 Takip Edilen
Superb to see this new ESMO - Eur. Oncology living guideline update in non-oncogene addicted metastatic NSCLC published. Great job authors Lizza Hendriks Martin Reck
⏰ Up next at #ELCC24: The controversy session begins at 2:30! 🎙️ The moderator: Dr. Rolf Stahel of ETOP IBCSG Partners Foundation 🤔 The controversy: The pros and cons of PROs ➕ We need more: Alona Zer of RambamHCC ➖ We need to simplify: Herbert Loong, MBBS, FASCO of The Chinese University of Hong Kong - CUHK ➡️ Don't miss it!
Thank you Dr. Rolf Stahel ETOP IBCSG Partners Foundation & Herbert Loong, MBBS, FASCO for collaborating in this #ELCC2024 controversy session The pros and cons of PROs and thanks to the audience nurses physicians and patient advocates- had a great time #LungCancer ESMO - Eur. Oncology
Thank you Marco Tagliamento Martin Reck Daniel Tan and Michal Lotem for a wonderful session & for demonstrating how wide is the world of IO beyond PD1 blockade #ELCC24
Best motivations for attending meetings is to catch up with #colleagues, #friends, #collaborators & #twitterpals from around the 🌎. Many a times these in corridor ‘hellos’ are brief, but it’s always great to keep in touch! #ELCC24 Alfredo Addeo MD Mark Awad Vamsi Velcheti, MD MBA FASCO
Last day and last hour of #ELCC2024 - this conference keeps delivering: Lizza Hendriks gives a comprehensive review on systemic therapy for CNS metastases 🧠 ESMO - Eur. Oncology
25 Posts Not To Miss From ELCC 2024 oncodaily.com/41993.html Dr. Antonio Calles 🫁🚭 Giannis Mountzios Stephen V Liu, MD Julien Mazieres Alfredo Addeo MD Jennifer C. King, PhD @esinghimd Mariana Brandao Charu Aggarwal, MD, MPH, FASCO Gerry Hanna Xiuning Le MD PhD Alona Zer giuseppe viscardi Noemi Reguart Jarushka Naidoo Cecilia Pompili MD PhD FACS #OncoDaily
The registrational enabling Spearhead-1 study shows that afami-cel, an engineered T cell targeting MAGEA4, has promising efficacy in synovial sarcoma and MRCLS paving the way for T cell therapy in solid tumors. Memorial Sloan Kettering Cancer Center MSK Department of Medicine Sarcoma Service at Memorial Sloan Kettering sciencedirect.com/science/articl…
In this #ASCO Educational Book📕 we summarize in EGFR mut🫁: ✏️New EGFR TKI options in early stage ✏️New options in metastatic setting ✏️Mechanisms of acquired resistance and new drugs 🧬 online at ascopubs.org/journal/edbk Thanks to Stephanie Saw Xiuning Le MD PhD Lizza Hendriks
Brilliantly discussed by Stephen V Liu, MD both SCLC abstracts: subgroup analysis of ADRIATIC and anti-flucosyl-GM1 #ESMO24 #LCSM
In Barcelona for #ESMO24 for just a few hours and already some great scientific discussions plus met with such wonderful thoracic oncology experts from around the world! #ESMOAmbassadors Fiona Blackhall Cecilia Pompili MD PhD FACS Alona Zer Chiara CATANIA
At the Palau Nacional for the #ESMO24 Presidential Dinner with Thoracic Oncology royalty! Solange Peters Enriqueta Felip Pilar Garrido Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ Dr. Antonio Calles 🫁🚭 Arielle Elkrief, MD FRCPC Bertrand Routy MD,PhD Ticiana Batista (Leal) Cecilia Pompili MD PhD FACS Isabelle Opitz Heather Wakelee Alona Zer #ESMOAmbassadors